Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05292781 · ClinicalTrials.gov registry record · NA
CHOICES3: Sickle Cell Disease Parenting CHOICES
A NA study of Sickle Cell Disease and Sickle Cell Trait, sponsored by University of Florida.
- Active
- Registry status
- NA
- Development phase
- 506
- Enrollment target
- 1
- Study location
NCT05292781: Active NA study of Sickle Cell Disease and Sickle Cell Trait, sponsored by University of Florida.
NCT05292781 is a NA study of Sickle Cell Disease and Sickle Cell Trait that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 506 participants, above the 290-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (74% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05292781, a NA study of Sickle Cell Disease and Sickle Cell Trait, is active but no longer recruiting, sponsored by University of Florida.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 506 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will use web-based data collection (SCKnowIQ) and intervention delivery strategies enhanced by nudges and tailored boosters in a sample of 430 adult men and women, aged 18-45 yr with SCD (Sickle Cell Disease) or SCT (Sickle Cell Trait), at-risk, and planning within 2 years to have a child free of SCD.
Primary Outcome
Knowledge. The Sickle Cell Reproductive Health Knowledge Questionnaire measures knowledge of the genetic transmission of SCD and SCT, etiology of SCD, parenting options for people with SCD or SCT, types of contraceptives safe for people with SCD or SCT, and risks of complications during pregnancy for the woman with SCD. Responses are multiple choice options. Scores are totaled across all items, ranging from 0 to 17; higher scores reflect better knowledge than lower scores.
Conditions Studied
Interventions
- OTHER CHOICES
- OTHER eBook
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 506 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What the registry record for NCT05292781 still lists
NCT05292781 is an interventional study that assigns participants to a tested intervention. The registered 506 participants enrollment target is mid-sized for trials with a published cap, above the 290-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (74% higher).
The record links to 2 conditions, with Sickle Cell Disease appearing as the primary indexed condition, and to 2 interventions - of which CHOICES is the first listed.
NCT05292781 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05292781 about?
NCT05292781 is a clinical study titled "CHOICES3: Sickle Cell Disease Parenting CHOICES". The study will use web-based data collection (SCKnowIQ) and intervention delivery strategies enhanced by nudges and tailored boosters in a sample of 430 adult men and women, aged 18-45 yr with SCD (Sickle Cell Disease) or SCT (Sickle Cell Trait), at-risk, and planning within 2 years to have a child ...
What is the current status of trial NCT05292781?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 506 participants. The study started on 2022-12-01. Estimated completion is 2027-06-30.
What conditions does trial NCT05292781 study?
This clinical trial studies the following conditions: Sickle Cell Disease, Sickle Cell Trait.
What interventions are being tested in trial NCT05292781?
The interventions under investigation include: CHOICES (OTHER), eBook (OTHER).
Who is sponsoring clinical trial NCT05292781?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05292781 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sickle Cell Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05292781's enrollment target sits among peer trials
506 5th of 213 higher than 209 of 213 other Sickle Cell Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sickle Cell Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Exercise in Child Health
RECRUITING · NA
-
Sickle Cell Children's Exercise Study (SuCCESs)
RECRUITING · NA
-
Cutaneous Hydration Assessment in SCD
RECRUITING · NA
-
MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05069428 · 506 participants · Phase 4
Delirium Reduction With Ramelteon
- NCT05797168 · 506 participants · Phase 1
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- NCT06164717 · 507 participants · NA
Behavioral and Neural Characteristics of Adaptive Speech Motor Control
- NCT02115295 · 508 participants · Phase 2
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI